Literature DB >> 20488262

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.

Jeffrey Partridge1, Marie Paule Kieny.   

Abstract

Immunization against influenza is considered among the most important interventions in reducing the public health impact of seasonal epidemic and pandemic influenza infections. However, there are marked differences across countries with regards to production, supply and access to influenza vaccines. A global action plan (GAP) to increase supply of pandemic influenza vaccine was developed by the World Health Organization in May 2006 to reduce the anticipated gap between potential vaccine demand and supply during an influenza pandemic. To quantify the increase in global influenza vaccine production capacity and actual production in response to the influenza A(H1N1) 2009 pandemic, 3 years after the development of the GAP, the WHO conducted a survey of vaccine producers from December 2009 through February 2010, and compared the results of this survey with results from surveys conducted in 2006-2007 and May 2009. Copyright 2010 World Health Organization. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488262     DOI: 10.1016/j.vaccine.2010.04.083

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  33 in total

1.  Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.

Authors:  Jennifer Humberd Smith; Mark Papania; Darin Knaus; Paula Brooks; Debra L Haas; Raydel Mair; James Barry; S Mark Tompkins; Ralph A Tripp
Journal:  Vaccine       Date:  2011-11-07       Impact factor: 3.641

2.  2009 Pandemic Influenza A (H1N1): Diagnosis, Management, and Prevention- Lessons Learned.

Authors:  Kristin A Swedish
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

3.  Intradermal delivery of vaccines: potential benefits and current challenges.

Authors:  J K Hickling; K R Jones; M Friede; D Zehrung; D Chen; D Kristensen
Journal:  Bull World Health Organ       Date:  2011-01-05       Impact factor: 9.408

Review 4.  Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Authors:  Monique P Curran; Isabel Leroux-Roels
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

5.  Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza.

Authors:  Ane Marie Anderson; Marta Baranowska-Hustad; Ranveig Braathen; Gunnveig Grodeland; Bjarne Bogen
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

6.  Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.

Authors:  Dominic Dwyer; Ian Barr; Aeron Hurt; Anne Kelso; Patrick Reading; Sheena Sullivan; Philippe Buchy; Hongjie Yu; Jiandong Zheng; Yuelong Shu; Dayan Wang; Annette Aguon; Rita Q Oliva; Takato Odagiri; Masato Tashiro; Khebir Verasahib; Mohd Apandi Yusof; Pagbajabyn Nymadawa; Burmaa Alexander; Anne-Claire Gourinat; Jean-Paul Grangeon; Lance Jennings; Sue Huang; Paul Horwood; Marilla Lucero; Vito Roque; Lyndon Lee Suy; Peter Cardon; Amado Tandoc; Remigio M Olveda; Chun Kang; Park Young-Joon; Jeffery Cutter; Raymond Lin; Constance Low; Le Thi Quynh Mai; Amanda Balish; James Kile; Shang Mei; Jeffrey Mcfarland; Ann Moen; Sonja Olsen; Gina Samaan; Xu Xiyan; Nora Chea; Sergey Diorditsa; Keith Feldon; Kimberley Fox; Mendsaikhan Jamsran; Frank Konings; Hannah Catherine Lewis; Michelle McPherson; Eric Nilles; Babatunde Olowokure; Jeffrey Partridge
Journal:  Western Pac Surveill Response J       Date:  2013-03-03

7.  Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice.

Authors:  Sehee Park; Jin Il Kim; Joon-Yong Bae; Kirim Yoo; Hyunung Kim; In-Ho Kim; Man-Seong Park; Ilseob Lee
Journal:  J Microbiol       Date:  2018-02-02       Impact factor: 3.422

Review 8.  The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.

Authors:  David S Fedson; Steven M Opal
Journal:  Hum Vaccin Immunother       Date:  2013-02-07       Impact factor: 3.452

9.  The coming era of quadrivalent human influenza vaccines: who will benefit?

Authors:  Ian G Barr; Lauren L Jelley
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

10.  Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.

Authors:  Jasdave S Chahal; Omar F Khan; Christopher L Cooper; Justine S McPartlan; Jonathan K Tsosie; Lucas D Tilley; Saima M Sidik; Sebastian Lourido; Robert Langer; Sina Bavari; Hidde L Ploegh; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.